Follow the people · Insider

KM

Keith S. Manchester

Insider · Director · ROIV

Keith S. Manchester files insider transactions with the SEC as a director of Roivant Sciences (ROIV). We hold 6 disclosed purchases and sales filed since 14 August 2015, 3 of them in the last 90 days.

  • Files forROIV
  • Disclosed buys and sells6 in all, 3 in the last 90 days
  • Last disclosure30 June 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 15 September 202230 June 2026Director · Roivant Sciences (ROIV)52 Form 4 lines · source: SEC Form 4
  • Filed 12 August 201514 August 2024Director · Arbutus Biopharma (ABUS)13 Form 4 lines · source: SEC Form 4

Everything they disclosed

65 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.